Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06512766
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
a Retrospective Study on the Systemic Treatment of LPP and FFA
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cicatricial Alopecia a Retrospective Study on the Systemic Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This retrospective study aims to assess the effectiveness of systemic treatments for lichen planopilaris LPP and frontal fibrosing alopecia FFA in patients treated at the Erasmus MC University Medical Center LPP and FFA are chronic inflammatory hair disorders leading to irreversible hair loss The study evaluates treatment responses to systemic medications including hydroxychloroquine methotrexate cyclosporine A and retinoids
Detailed Description:
Cicatricial alopecia also known as scarring alopecia refers to a group of rare chronic inflammatory hair disorders resulting in irreversible hair loss Lichen planopilaris LPP and frontal fibrosing alopecia FFA are the most common forms of primary lymphocytic cicatricial alopecia affecting predominantly postmenopausal women These conditions lead to significant quality of life impairment due to their chronic nature and the lack of effective standardized treatment protocols The study aimed to address the gap in evidence-based treatment guidelines by investigating the effectiveness of various systemic therapies currently used in clinical practice The retrospective cohort study reviewed medical records of patients diagnosed with LPP or FFA at the Department of Dermatology Erasmus MC University Medical Center from July 2016 to July 2022
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None